BDBM50141194 3,4-Dihydro-1H-isoquinoline-2-carboxylic acid (S)-1-((R)-3-methyl-2-{(R)-3-methyl-2-[(pyrazine-2-carbonyl)-amino]-butyrylamino}-butyryl)-5-[(R)-1-(2-oxo-2-phenyl-acetyl)-butylcarbamoyl]-pyrrolidin-3-yl ester::CHEMBL285686

SMILES: CCCC(NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@H](NC(=O)[C@H](NC(=O)c1cnccn1)C(C)C)C(C)C)OC(=O)N1CCc2ccccc2C1)C(=O)C(=O)c1ccccc1

InChI Key: InChIKey=BGKDCLMBGNPIKR-RXNVYWLJSA-N

Data: 1 KI  1 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50141194   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Hepatitis C virus serine protease, NS3/NS4A (Hepatitis C virus)	BDBM50141194 (3,4-Dihydro-1H-isoquinoline-2-carboxylic acid (S)-...) Show SMILES CCCC(NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@H](NC(=O)[C@H](NC(=O)c1cnccn1)C(C)C)C(C)C)OC(=O)N1CCc2ccccc2C1)C(=O)C(=O)c1ccccc1 Show InChI InChI=1S/C42H51N7O8/c1-6-12-31(37(51)36(50)28-14-8-7-9-15-28)45-39(53)33-21-30(57-42(56)48-20-17-27-13-10-11-16-29(27)23-48)24-49(33)41(55)35(26(4)5)47-40(54)34(25(2)3)46-38(52)32-22-43-18-19-44-32/h7-11,13-16,18-19,22,25-26,30-31,33-35H,6,12,17,20-21,23-24H2,1-5H3,(H,45,53)(H,46,52)(H,47,54)/t30-,31?,33+,34-,35-/m1/s1	PDB UniProtKB/TrEMBL GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	<200	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Vertex Pharmaceuticals Inc. Curated by ChEMBL					Assay Description Binding inhibition of hepatitis C virus NS3.4A protease 2 using p-nitroaniline assay (pNA); <0.2 (0.03)				Bioorg Med Chem Lett 14: 1441-6 (2004) Article DOI: 10.1016/j.bmcl.2004.01.022 BindingDB Entry DOI: 10.7270/Q24Q7TD2
					More data for this Ligand-Target Pair
Hepatitis C virus serine protease, NS3/NS4A (Hepatitis C virus)	BDBM50141194 (3,4-Dihydro-1H-isoquinoline-2-carboxylic acid (S)-...) Show SMILES CCCC(NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@H](NC(=O)[C@H](NC(=O)c1cnccn1)C(C)C)C(C)C)OC(=O)N1CCc2ccccc2C1)C(=O)C(=O)c1ccccc1 Show InChI InChI=1S/C42H51N7O8/c1-6-12-31(37(51)36(50)28-14-8-7-9-15-28)45-39(53)33-21-30(57-42(56)48-20-17-27-13-10-11-16-29(27)23-48)24-49(33)41(55)35(26(4)5)47-40(54)34(25(2)3)46-38(52)32-22-43-18-19-44-32/h7-11,13-16,18-19,22,25-26,30-31,33-35H,6,12,17,20-21,23-24H2,1-5H3,(H,45,53)(H,46,52)(H,47,54)/t30-,31?,33+,34-,35-/m1/s1	PDB UniProtKB/TrEMBL GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	26	n/a	n/a	n/a	n/a	n/a	n/a
Vertex Pharmaceuticals Inc. Curated by ChEMBL					Assay Description Binding inhibition of hepatitis C virus NS3.4A protease 2 using a reverse phase HPLC based assay				Bioorg Med Chem Lett 14: 1441-6 (2004) Article DOI: 10.1016/j.bmcl.2004.01.022 BindingDB Entry DOI: 10.7270/Q24Q7TD2
					More data for this Ligand-Target Pair